Skip to main content
. 2025 Jan 24;111(3):2358–2375. doi: 10.1097/JS9.0000000000002227

Table 2.

Characteristics of All RCTs

Characteristic RCTs, NO. (%) N = 182
Time of registration
 2003–2008 76 (41.8)
 2009–2013 44 (24.2)
 2014–2018 29 (15.9)
 2019–2023 33 (18.1)
Intervention
 Drug 127 (69.8)
 Procedure 34 (18.7)
 Device 12 (6.6)
 Other 9 (4.9)
Primary purpose
 Treatment 158 (86.8)
 Prevent 1 (0.5)
 Support care 1 (0.5)
 Other 22 (12.1)
Intervention model
 Parallel 152 (83.5)
 Factorial 2 (1.1)
 Crossover 28 (15.4)
Arm
 2 151 (83.0)
 3 22 (12.1)
 ≥4 6 (3.3)
 Missing 3 (1.6)
Blinding
 None or open label 49 (26.9)
 Single 17 (9.3)
 Double 66 (36.3)
 Triple 19 (10.4)
 Quadruple 31 (17.0)
Recruitment
 Monocentric 76 (41.8)
 Multicenter 100 (54.9)
 Missing 6 (3.3)
Funder type
 None or departmental 91 (50.0)
 Industry or other external 91 (50.0)
Region of PI
 North America 65 (35.7)
 Europe 44 (24.2)
 Asia 65 (35.7)
 South America 4 (2.2)
 Oceania 4 (2.2)
Region of PI
 HAQ<90 164 (90.1)
 HAQ≥90 18 (9.9)
Region of PI
 High Income 144 (79.1)
 Nonhigh income 38 (20.9)
Region of PI
 High SDI 138 (75.8)
 Nonhigh SDI 44 (24.2)